Atalar E, Konak HE, Dağlı PA, Ulusoy BÖ, Karakaş Ö, Orhan K, et al. Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab. Reumatismo [Internet]. 2025 Jun. 26 [cited 2026 Oct. 24];77(3). Available from: https://www.reumatismo.org/reuma/article/view/1792